Clinical trial looks at tramadol for opioid withdrawal

A randomized clinical trial published by JAMA Psychiatry compared tramadol extended-release with clonidine and buprenorphine for the management of opioid withdrawal symptoms in patients with opioid use disorder in a residential research setting.

Opioid use disorder is a public health problem that has contributed to unprecedented levels of overdose deaths. Detoxification - or medically supervised withdrawal - is a widely used treatment for opioid use disorder. However, failing to adequately manage opioid withdrawal symptoms can contribute to people leaving treatment.

Clonidine and buprenorphine are two medications widely used to manage opioid withdrawal. Tramadol hydrochloride is a promising alternative option for effective opioid use disorder treatment, according to the article.

Kelly E. Dunn, Ph.D., of the Johns Hopkins University School of Medicine, Baltimore, and coauthors conducted a in a residential research setting with 103 patients, mostly men, with opioid use disorder. During a seven-day taper, clonidine, buprenorphine or tramadol hydrochloride extended-release, which is an approved analgesic with low abuse potential, were used.

The clinical trial showed tramadol extended-release suppressed withdrawal more than clonidine and was comparable to buprenorphine during a residential tapering program, according to the article.

The study notes some limitations, including a primarily male sample and a lack of specific information regarding past 30-day use of other illicit drugs and alcohol.

"These data suggest that tramadol ER is a promising and valuable medication for the management of opioid withdrawal in patients undergoing treatment for OUD [ use disorder]. Future studies should evaluate whether relapse varies following supervised withdrawal with tramadol ER vs. other medications and whether ER can be used to transition patients to naltrexone ," the article concludes.


Explore further

Injectable therapy blocks opioid euphoria, withdrawal symptoms in trial

More information: JAMA Psychiatry (2017). doi:10.1001/ jamapsychiatry.2017.1838
Journal information: JAMA Psychiatry

Citation: Clinical trial looks at tramadol for opioid withdrawal (2017, July 12) retrieved 24 May 2019 from https://medicalxpress.com/news/2017-07-clinical-trial-tramadol-opioid.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
1 shares

Feedback to editors

User comments

Jul 13, 2017
@lying pseudoscience fraud bubba the quack
cures oxycodone addiction
there is absolutely no scientific evidence that supports your assertions in any journal, anywhere

this is called a religious belief

religion often thinks that repeating a lie makes it more true
this may work with cults, but it is not in any way science, nor does it work with people who are capable of seeking valid information to substantiate a claim

considering your attempt to sell your pseudoscience, you must be starting your own cult and are seeking acolytes

enjoy your jail time for fraud
reported

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more